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SUMMARY 
The nucleotide sequence of a clone containing mouse carbonic anhydrase (CA) eDNA in pBR322 has been 
determined. The cloned eDNA contains all of the coding region except for nueleotides specifying the first eight 
amino acids, and all of the 3' noncoding region, which consists of 700 nucleotides. A eDNA clone was identified 
which contains an additional 54 bp at the 5' end, so that the complete amino acid sequence of mouse CA could 
be deduced. This sequence showed a 73-81% homology with other mammalian CA form II isozymes, 56--63 
with form I isozymes, and 52-56 ~o with form III isozymes. By examination of the amino acids which are unique 
and invariant for each isozyme, the mouse amino acid sequence was found to contain 16 of the 23 residues 
that are unique and invariant to mammalian CA form II isozymes, but only one or no residue for forms I and 
III, respectively. 
INTRODUCTION 
The carbonic anhydrases (EC 4.2.1.1) are zinc 
metalloenzymes of apparently great evolutionary 
antiquity which catalyze the reversible hydration of 
CO2 (for recent reviews see Pocker and Sarkanen, 
1978; Lindskog, 1982; Tashian et al., 1983). At least 
three isozymes of CA, termed CA I, CA II and 
* To whom correspondence and reprint requests should be sent 
at the first address. 
Abbreviations: bp, base pairs; CA, carbonic anhydrase. 
CA III, appear to be characteristically present in 
amniotes (reptiles, birds and mammals) where they 
are under the control of separate genetic loci. The 
CA II genes are expressed in a wide variety of cells 
and tissues, whereas the CA I and CA III genes 
seem to have a more limited tissue expression 
(Tashian, 1977; Tashian et al., 1983). 
The complete, or partially (>60~o) complete, 
amino acid sequences of six CA I, seven CA II and 
two CA III isozymes have now been determined 
from 11 species of mammals (Tashian et al., 1983). 
These are all monomeric enzymes 259 or 260 amino 
acid residues in length (Mr approx. 29000). When 
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the sequences of all of these CA isozymes are com- 
pared, about 30~ of the residues were found to be 
identical. Despite this relatively high degree of evolu- 
tionary homology, however, the often disparate 
physicochemical and kinetic properties, and con- 
siderable variation in tissue distribution of the CA 
isozymes, suggest different physiological roles for 
each isozyme. 
Although some limited sequence data have been 
obtained for the CA III isozyme of the rat (Carter 
et al., 1981), and what appears to be CA II cDNA 
from the mouse (Curtis, 1983), no extensive nucleo- 
tide or amino acid sequences are as yet available for 
a CA isozyme from any rodent species. In this 
respect, it will be very useful to determine the 
sequences of the CA isozyme genes of mice, not only 
because of their obvious relevance to evolutionary 
and genetic studies, but also because of their potential 
use in developmental studies where it is important to 
identify the CA isozymes, e.g., during normal red cell 
development, or in transformed mouse erythroleu- 
kemia cells (Curtis, 1983). In the present report, the 
complete nueleotide sequence which includes the 
entire coding region, of mouse CA cDNA cloned 
from the mRNA purified from mouse anemic spleen 
has been determined, and identified as CA II by 
comparison with the known sequences of other 
mammalian CA isozymes. 
MATERIALS AND METHODS 
(a) Isolation of plasmid clones 
The characterization of a clone which contained 
CA mRNA derived from Balb/c mice, p6-69, has 
been described (Curtis, 1983) and shall be designated 
as pMCAII. Plasmid was isolated from Escherichia 
coli containing pMCAII by the procedure of Ish- 
Horowitz and Burke (1981). 
Additional plasmids containing CA sequences 
were identified in a plasmid library containing eDNA 
sequences from mouse anemic spleen. To make the 
plasmid eDNA library, double-stranded DNA was 
synthesized from poly(A) + RNA of mouse anemic 
spleen, treated with S 1 nuclease, tailed with dCMP 
residues and selected for a size greater than 1000 bp 
(Curtis, 1983). The tailed DNA was annealed with 
dG-tailed pBR322 and the hybrid DNA used to 
transfect E. co/i HB101. One million tetracycline- 
resistant colonies were collected from the agar plates 
and plasmid extracted as described above. The 
pooled plasmid DNA was used to transfect E. coli. 
To screen the colonies, pMCAII was cut with PstI 
and fragments derived from the cloned sequences 
were purified by agarose gel electrophoresis and 
labeled using calf thymus primers and E. coli DNA 
polymerase I (Summers, 1975). 
(b) DNA sequencing 
Restriction fragments derived from pMCAII by 
digestion with PstI, BamHI and HindlII, were sub- 
cloned into M13mp8 and sequenced by the dideoxy 
chain termination method (Sanger etal., 1977; 
Messing and Vieira, 1982). Additional sequences 
were determined by the procedure of Maxam and 
Gilbert (1977) using 3' end-labeled restriction frag- 
ments. 
RESULTS AND DISCUSSION 
(a) Strategy of DNA sequencing 
The plasmid pMCAII for mouse CA contains an 
insert of about 1500 bp with two internal PstI sites 
resulting in three fragments of 700, 450, 320 bp 
(Fig. 1). These fragments were cloned into M13mp8 
cut with Psi I. The resultant six clones were sequenced 
by the dideoxy chain termination method. The two 
smaller fragments were sequenced completely. For 
the larger fragment, the middle section of the 
sequence was obtained from M13mp8 clones 
containing the BamHI-BglII fragment as well as the 
HindIII-PstI. Additional segments were sequenced 
by the Maxam and Gilbert method (1977). After 
digestion separately with BamHI and HindlII, the 
3' ends were labeled, and singly labeled fragments 
produced by further digestion with restriction en- 
zymes were purified by agarose gel electrophoresis. 
The sequence derived from pMCAII could be 
translated into an amino acid sequence that shared 
extensive homology with the other mammalian 
CA II isozyme sequences. When these amino acid 
sequences were aligned, the sequence for the first 
5' end of mRNA 
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Fig. 1. Restriction map of pMCAII. The arrows indicate the direction and extent of the sequence that was determined by the chain 
termination method and by the Maxam and Gilbert (]977) procedure. 
eight amino acids from the N terminus was missing. 
In order to obtain this sequence, a library of mouse 
cDNA sequences derived from poly(A)+RNA of 
anemic spleen was screened using the inserted 
sequences of pMCAII as a labeled probe. Approx. 
100 colonies were identified, of which 20 were 
selected with the strongest response. Plasmid was 
prepared from these colonies, digested with Pst I and 
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Fig. 2. Agarose gel electrophoresis of plasmids containing 
mouse CA eDNA. Plasmids were digested with Psi I and electro- 
phoresed in a 1.5% agarose gel. Lanes I, 3: two plasmids 
containing CA II eDNA. Lane 2: pMCAII. 
analyzed by agarose gel electrophoresis (Fig, 2). 
From the sequencing it had been determined that the 
320-bp fragment contained sequences of the 5' end 
of the mRNA, the 450-bp fragment contained sees 
quences of the 3' end of the coding region of the 
mRNA, while the 700-bp fragment contained almost 
all of the 3' noncoding region. Two plasmids were 
identified which contained the 450-bp fragment, but 
had a fragment of approx. 350-400 bp instead of a 
320-bp fragment. They also had a third fragment 
somewhat smaller than the 700-bp fragment of 
pMCAII. Presumably these two plasmids contain 
extra sequences at the 5' end, but lack sequences 
from the 3' end. The shortened 3' end probably 
arose from incomplete synthesis of the double,- 
stranded eDNA. Only one RNA species was detect- 
ed by hybridization ofpMCAII to RNA fractionated 
by gel electrophoresis and transferred to amino- 
phenylthioether paper (not shown). In addition the 
size of the 3' end fragment was variable in several 
different plasmids and there is only one poly(A) 
addition site in the 3' noncoding sequence. The two 
plasmids were digested with PstI and Bali and the 
digest ligated to M13mp8 digested with PstI and 
Sinai. The appropriate clones of M 13 were identified 
by a hybridization test with a M13 clone containing 
the 320-bp fragment of pMCAII. The M13 clones 
derived from the two plasmids were sequenced as 
above. 
The combined nuclootidc sequences are shown in 
3 2 8  
TCC CAC CAC TGG GGA TAC AGC AAG CAC AAC GGA CCA GAG AAC TGG 
Set His Hts Trp Gly Tyr Set Lys His Asn Gly Pro Glu As.._~n Trp 
1 15 
GAT ATT GAC ACA GCA ACT GCC CAC CAT GAC CCT GCC CTA CAG CCT 
Asp I le  Asp Thr Ala Thr Ala Hts His Asp Pro Ala Leu Gl_.~n Pro 
45 
AAC GGC CAC TCC TTT AAC GTT GAG TTT GAT GAC TCT CAG GAC 
Asn Gly Hts Set Phe Asn Val GIu Phe Asp Asp Set Gln Asp 
CAG TTT CAC TTT CAC TGG GGC TCA TCT GAT GGC CAG GGC TCT 
Gin Phe Hts Phe His TPp Gly $er Set Asp Gly Gin Gly Ser 
CAC TGG AAC ACC AAA TAT GGG GAC TTT GGA AAA GCT GTG CAG 
HfS Trp Asn Thr kys Tyr Gly Asp ~he Gly kys Ala Val Gin 
GCC TCA CAA GGC CTT CAG AAA GTC CTT GAA GCA CTG CAT TCC 
Ala Set Gln Gly Leu Gln Lys Val Leu Gl__~u Ala Leu His Ser 
TCC CTT CTT CCT GGA AAC TTG GAC TAC TGG ACA TAC CCT GGC 
Ser Leu Leu Pro Gly As.._nn Leu Asp Tyr Trp Thr Tyr Pro Gly 
AGG GAG CCC ATT ACT GTC AGC AGC GAG CAG ATG TCT CAT TTC 
Ar9 Glu Pro l i e  Thr Val Set Set Glu Gin Her Ser His Phe 
GAC AAC TGG CGT CCA GCT CAG CCG CTA AAG AAT AGA AAG ATC 





CAC AAG GAC TTC CCC ATT GCC AAT GGA GAC CGG CAG TCC CCT GTG 
His Lys Asp Phe Pro l i e  Aia Asn Gly Asp Ar9 Gln Set Pro Val 
30 
210 
CTG CTC ATA TCT TAT GAT AAA GCT GCG TCC AAG AGC ATT GTC AAC 
Leu Leu l i e  Ser Tyr Asp Lys Ala Ala Set Lys Set l i e  Val Ash 
60 
300 
AAT GCA GTG CTG AAA GGA GGA CCC CTC AGT GAC TCC TAC AGA TTG ATC 
Asn Ala Val Leu Lys Gly Gly Pro Leu Ser Asp Ser Tyr Ar 9 Leu l l e  
--7~ 90 
390 
GAG CAC ACT GTG AAC AAA AAA AAA TAT GCT GCA GAG CTT CAC TTG GTT 
Glu His Thr Val Asn Lys Lys Lys Tyr Ala Ala Glu Leu His Leu Val 
105 120 
480 
CAA CCG GAT GGA TTG GCT GTT TTG GGC TAT TTT TTG AAG ATT GGA CCT 
Gln Pro Asp Gly Leu Ala Val Leu Gly Tyr Phe Leu Lys l i e  Gly Pro 
135 T6~ 
fi/O 
ATT AAA ACA AAG GGG AAG CGT GCG GCC TTT GCT AAC TTC GAC CCT TGC 
[ le  Lys Thr Lys Gly Lys Ar9 Ala Ala Phe Ala Asn Phe Asp Pro Cys 
165 ~ - -  
660 
TCT CTG ACC ACT CCG CCT CTG CTG GAP, TGT GTG ACC TGG ATC GTG CTC 
$er Leu Thr Thr Pro Pro Leu Leu G|u Cys Val Thr Trp l i e  Va| |eu 
195 210 
75O 
CGT ACG CTG AAC TTC AAT GAG GAG GGG GAT GCT GAA GAA GCG ATG GTG 
Ar9 Thr Leu Asn Phe Asn Glu Glu GJy Asp Ala G|u Glu Ala Her Val 
225 - -  ~ 240 
810 840 
AAA GCG TCC TTT AAG TAAAACAACCCTGCAGCAGGGGTCCGAAGGCACAAGTGT 
kys Ala Set Phe Lys 
255 
880 930 960 
GAcCGCCTCTCTGTAGCTAAGCGCAGTTA•GG•TGGGTGATTTGGATC•CGACT•GcAT•TGGTATTGTAGAC•TTTTAC•TCT•ATCCGTTGTG•TTACTAA•AAAAG•AAGA••CAGG 
1000 1050 1080 
TGTCTCATGTGGTGGCAGCACAGTGGCAGGCCAGTGGTCAACTTAGGGCATCTTTTCTCTGCCACGGCAG~GCAATGCAAAGAGCAGA~ATGGCCTCTTG~TTCTCTTCACAGCCATAG G 
1120 I170 1200 
ATAATGAA•A•TCAGG••TGHTGTTAAAATG•TATTTTAAAA••A•A•GAAGGTAGGATAATTAATTACAAGT•CA•AT•ATGAGA•AAACTGAAGTAACTT•GGCAAAACAGGTAAAC 
1240 1290 1320 
AGT•ATAGTHT•TGATTATAAATGAG•T•AATGTTCA•C•TTC•AAGA••TTATATTAAAGAAAAAA•TTTAAAAAGCTTATATATTTGTAG•AAAGTTATT•TTAAATA•GAATTATG 




Fig. 3. Nucleotide sequence of cloned mouse CA II eDNA and the deduced amino acid sequence. The underlined amino acid residues 
are unique to the mouseCAII  sequence as compared to the CAII sequence ofhuman, sheep, ox, rabbit and horse. 
Fig. 3. There are 27 nucleotides preceding the initia- 
tion codon in the 5' noncodingregion: No homology 
was found in the 5' noncoding region with globin 
mRNA. Examination of the coding region shows 
that the use of triplets does. not differ significantly 
from the distribution found in globin mRNA 
(Kafatos et al., 1977; Heindell et al., 1978; Curtis, 
1980), except that in CA II the triplet CUG for leu- 
cine is not used as extensively as in giobin, while for 
glycine, GGA is used frequently and G G U  is not 
used at all. However, since CA. II constitutes < 1 
of total protein in most mammalian erythrocytes as 
well as being present at low levels in almost all tissues 
(Tashian, 1977), it is less likely to be affected by the 
relative concentrations of tRNAs which in reticulo- 
cytes correlates with the amino acid composition of 
globin (Smith, 1975). The growing number of pro- 
cessed transcripts characterized by long (>  500 bp) 
noncoding regions (e.g., dihydrofolate reductase 
mRNA, porcine fl-neo-endorphin mRNA, seal myo- 
globin gene, human plasminogen activator mRNA, 
and human hypoxanthine phosphoribosyltransferase 
mRNA; Setzer et al., 1980; Kakidani et al., 1982; 
Blancetot etal., 1983; Penniea etal., 1983; Jolly 
et al., 1983) suggests that such a phenomenon may 
not  be as uncommon as previously thought. How- 
ever, no significance has as yet been associated with 
large 3'-nontranslated regions. In CA II mRNA 
following the termination signal the same reading 
frame remains open for 324 nucleotides before 
several stop codons are encountered. It would be of 
interest to know if read-through of the normal termi- 
nation signal occurs at all. Located 18 nucleotides 
from the beginning of the poly(A) region at the 3' end 
is the sequence AATAAA which is found in all 
poly(A) ÷-containing mRNAs and acts as a signal 
either for cleavage of the pre-mRNA or as a recogni- 
tion site for polyadenylation. 
(b) Ident i f i cat ion  o f  the m o u s e  C A  c D N A  as  a C A  II 
i s o z y m e  
From the nucleotide sequence, the complete amino 
acid sequence of a mouse CA was deduced. One of 
the most effective methods that can be used to assign 
an unknown CA to a specific isozyme type (i.e., 
CA I, CA II or CA III) is to compare the residues in 
its sequence to those residues which are invariant in 
all examples of that isozyme sequenced to date, but 
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TABLE II 
Comparison of mouse CA II amino acid sequence with amino 
acid sequences from selected mammalian CA isozymes 
Species a CA isozymes 
CA I CA II CA III 
Residues identical to mouse CA II (~) 
Human 63 81 56 
Rabbit 56 77 - 
Ox 58 75 52 
Horse 58 78 - 
a See footnote to Table III for references. 
have a different residue at this position in the other 
two isozymes. For example, all ofthe CA II isozymes 
have His residues at positions 2 and 3 (as does the 
mouse CA isozymv), whereas the His does not 
appear at these positions in any of the CA I or CA III 
isozymes. This information is summarized in Table I. 
As can be seen, the mouse CA sequence shows only 
one residue in common with the 21 residues that are 
unique and invariant in the CA I isozymes, and no 
residues in common with the 31 residues unique to 
the CA III isozymes. However, the fact that 16 of the 
23 residues that were considered previously to be 
unique and invariant to the CA H isozymes were 
identical to the mouse sequence, strongly suggests 
that the mouse CA sequence is most closely related 
to the CA II isozymes ofmammals. The fact that the 
mouse CA II has different amino acids in seven 
positions, which are invariant in all other CA IIs, 
may be related to the unusual properties of mouse 
CA II, as discussed below. 
TABLE I 
Comparison of the putative mouse CA II amino acid sequence with the unique and invariant residues of mammalian CA I, CA II and 
CA III isozymes 
CA isozyme Number of species Number of unique 
sequenced a and invariant 
residues 
Number of mouse "CA IF' residues identical 
to the unique and invariant residues of Other 
CA isozymes (~) 
CA I 6 21 1 (5) 
CA II 7 23 b 16 (70) 
CA III 2 31 0 (0) 
a For references to these CA isozyme sequences, see Tashian et al. (1983) and citations therein. 
b These are at positions 2, 3, 7, 18, 26, 55, 57, 66, 68, 75, 86, III, 124, 127, 128, 130, 136, 164, 171,173, 228, 229, 253 in Fig:3. 
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(c) Evolutionary considerations 
The fact that all three CA isozymes are probably 
present in all species of amniotes indicates that the 
duplications which gave rise to the CA isozyme 
genes occurred more than 300 million years ago 
(Tashian et al., 1983). Over this evolutionary period, 
it appears that the CA I and CA II genes have 
remained closely linked since they have been assigned 
to a region close to the centromere of chromosome 
3 in the mouse (Eicher et al., 1976), and in all 
likelihood, are also linked on chromosome 8 in 
humans (Venta et al., 1983). Pairwise comparisons 
of the mouse CA II sequence with the sequences of 
the other CA isozymes (Table II) provide an appro- 
ximation of the evolutionary distances among these 
isozymes. As can be seen in Table II, the mouse 
CA II shows a 73-81~o homology with the CA II 
isozymes, a 56--63% homology with the CA I iso- 
zymes, and a 52 and 56~ homology with the CA III 
isozymes. 
(d) Residues unique to the mouse CA II sequence 
The following discussion of the residue positions 
of the mouse CA II isozyme is based on the assump- 
tion that its three-dimensional structure is similar to 
that of human CA II. For references to the high- 
resolution molecular structure of human CA II, see 
Vaara (1974) and Notstrand et al. (1975). When the 
mouse CA II sequence is compared with the com- 
plete CA II sequences of human, sheep, ox, rabbit 
and horse (for references, see footnote to Table III), 
33 residues were found to be unique to the mouse 
sequence and these are underlined in Fig. 3. All but 
five of the 33 residues are located on the surface of 
the human CA II molecule. It is of interest that 15 of 
the 33 amino acids are invariant in the non-mouse 
sequences. These residues which are listed in 
Table III, may contribute to the somewhat unusual 
properties that have been observed for the mouse 
CA II isozyme. These properties include the rela- 
tively rapid alterations (probably as a consequence 
of aging) in their high-pressure liquid chromato- 
graphy elution patterns and electrophoretic patterns 
comp"ared to the more stable patterns of the CA II 
isozymes of other mammals (D. Hewett-Emmett 
and Y.-S.L. Yu, unpublished observations). With 
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the effect of extending c~-helix E at its N-terminus, no 
obvious changes in secondary structures, aromatic 
clusters and hydrophobic core residues would appear 
to result from the amino acid differences at these 15 
positions. Of the remaining 18 residues unique to 
mouse CA II but variable in the CA II isozymes of 
other mammals, two residues (Tyr- 144 and Cys-180) 
are of interest. The residues at position 144 in the 
other CA II isozymes are Ile, Leu and Val. Residue 
144 is located in the middle of fl-structure segment 6 
and has been assigned to the hydrophobic core of the 
human CA II molecule. The presence of Tyr at this 
position (since it is less hydrophobic than Ile, Val 
and Leu) might affect the stability of the mouse 
CA II molecule. The residue at position 180 is Arg, 
Ser or Gly in the other CA II isozymes and is located 
in 3~o-helix F of human CA II. Since this residue is 
found on the surface of the human CA II molecule, 
it is possible that Cys-180 in mouse CA II may form 
intermolecular dimers with other CA II molecules. 
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